Related Experiment Video
Updated: May 18, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Clinical characteristics and mortality of heart failure. INCAex study
D Fernández-Bergés1, L Consuegra-Sánchez, F J Félix-Redondo
1Sección Cardiología, Departamento de Medicina Interna, Hospital Don Benito-Villanueva, Badajoz, España. polonibo@gmail.com
Insights
Mortality from decompensated heart failure declined over a decade, despite an aging patient population. Age, diabetes, and chronic renal failure predicted mortality, while oral anticoagulation showed protective effects.
Area of Science:
- Cardiology
- Public Health
- Geriatrics
Background:
- Heart failure represents a significant burden on healthcare expenditure and is a leading cause of cardiovascular death.
- Understanding trends in clinical features and prognostic factors is crucial for improving patient outcomes.
Purpose of the Study:
- To analyze the evolution of clinical characteristics and prognostic factors in patients hospitalized for decompensated heart failure over a 10-year period.
- To assess changes in patient demographics, treatment patterns, and mortality rates.
Main Methods:
- An observational, retrospective, single-center study was conducted.
- Consecutive patients admitted for decompensated heart failure between 2000 and 2009 were included.
- Data were analyzed across four 30-month periods to identify trends.
Main Results:
- A total of 2220 patients (mean age 76.3 years, 54% female) were studied.
- Significant increases were observed in patients over 75 years and in the prescription of beta-blockers, statins, and oral anticoagulants.
- Hospital mortality decreased from 13% to 8%, and one-year mortality decreased from 30% to 23%.
Conclusions:
- Despite an aging population, overall mortality in decompensated heart failure patients has significantly decreased over the decade.
- Independent predictors of one-year mortality included advanced age, diabetes, and chronic renal failure.
- Oral anticoagulation emerged as a protective factor against mortality.
Background And Objectives:
Heart failure is responsible for a major part of hospital health expenditure and the third cause of cardiovascular death. To describe the evolution of clinical features, and factors related to prognosis of patients admitted due to decompensated heart failure in a region of Extremadura during a period 10 years.
Patients And Methods:
Observational, retrospective and single centre study of consecutive patients admitted due to decompensated heart failure in a general hospital in the province of Badajoz, during the period 2000/2009.
Results:
A total of 2220 patients with mean age of 76.3 (SD±10.1), being 54% female were included in the study. Stratified into four periods (30 months each), a significant increase in patients over 75 years was observed (55 vs. 71%; P<.001), as well as an increase in the prescription of beta blockers at discharge (12 vs. 34%, P<.001), statins (8 vs. 31%; P<.001), and oral anticoagulants (13 vs. 25%; P<.001). Hospital mortality significantly decreased from 13 to 8% (P<.01), and from 30 to 23% (P<.01) at one year follow-up. Age (HR per year=1.04 [95% CI: 1.02 to 1.05]), diabetes (HR=1.35 [95% CI: 1.11 to 1.66]) and chronic renal failure (HR=1.49 [95% CI: 1.18 to 1.87]) were identified as independent predictors of all-cause mortality at one year of follow-up.
Conclusions:
Total mortality in patients with decompensated heart failure has declined significantly over the last decade, despite the increasing age. Age, diabetes and chronic renal failure were independent predictors of total mortality at one year. Oral anticoagulation was a protective factor.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure III: Clinical Manifestations
Heart Failure I: Introduction
Heart Failure VII: Nursing Interventions
Heart Failure II: Pathophysiology